Author Archive: BIOtechNOW Editor

Biosimilars Ahead, Proceed with Caution

Richard Dolinar

By Richard M. Dolinar, M.D., Chairman, Alliance for Safe Biologic Medicines In today’s budget-constrained world, the goal for health care is not only to save lives but also to save money. On Friday, May 11, the Food and Drug Administration (FDA) will hold a one-day public hearing on important medicines, known as biosimilars, that are under FDA consideration to come to the United States (U.S.) and offer the opportunity to help achieve the second prong Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , , , , ,

Help Children and Adults with Brittle Bones During OI Awareness Week

Mallie

By Stuart Tart, Director of Development, Osteogenesis Imperfecta Foundation Ten years ago, Greg and wife Leigh brought their new daughter, Mallie, home from the hospital. When she was 9 days old, Mallie was fussy, leading Greg and Leigh to discover that their baby girl had fractured her right tibia and fibula.  The new parents immediately took their daughter to the doctor, who advised them to take Mallie straight to the emergency room. They discovered that Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , ,

American Invents Act Strategies Highlighted at the IPCC Conference

Saravitz_David-NEW

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Spring Conference kicked off with a panel on the America Invents Act (AIA).  The panel focused on how practitioners and the U.S. Patent & Trademark Office (USPTO) are dealing with various provisions of this new patent act. Mr. Ira Finkelstein, Senior Patent Counsel with Baxter Healthcare, led off the session initially discussing the first-inventor-to-file provision of the AIA (§ Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BioManufacturers Increasing Budgets for New Technologies

Eric Langer

By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost two-thirds (64.2 percent) of biomanufacturers will increase their budgets for new technologies to improve efficiencies and costs for downstream production this year. Data from our newly released 9th Annual Report and Survey of Biopharmaceutical Manufacturers, include responses from 302 global biomanufacturers, and an additional 185 vendors to the industry. We find that budget increases this year are not just incremental Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotech Patent Case Law Updates at the IPCC

cox-john

By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Conference, held in Austin, Texas, provided an excellent forum for intellectual property (IP) practitioners in the biotech industry to socialize, network, and participate in panel discussions focusing on the dynamic developments in the patent laws.  The conference began for the general participants over margaritas and Tex-Mex fare, where attendees were already discussing recent Supreme Court and Federal Circuit decisions Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,